Cargando…

Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure

A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to changes in the cardiac energy metabolism that can lead to a loss of metabolic flexibility and to unfavorable clinical outcomes. We conducted an association analysis of 31 ASCVD phenotypes and 97 whole bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Beuchel, Carl, Dittrich, Julia, Pott, Janne, Henger, Sylvia, Beutner, Frank, Isermann, Berend, Loeffler, Markus, Thiery, Joachim, Ceglarek, Uta, Scholz, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949022/
https://www.ncbi.nlm.nih.gov/pubmed/35323659
http://dx.doi.org/10.3390/metabo12030216
_version_ 1784674794724130816
author Beuchel, Carl
Dittrich, Julia
Pott, Janne
Henger, Sylvia
Beutner, Frank
Isermann, Berend
Loeffler, Markus
Thiery, Joachim
Ceglarek, Uta
Scholz, Markus
author_facet Beuchel, Carl
Dittrich, Julia
Pott, Janne
Henger, Sylvia
Beutner, Frank
Isermann, Berend
Loeffler, Markus
Thiery, Joachim
Ceglarek, Uta
Scholz, Markus
author_sort Beuchel, Carl
collection PubMed
description A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to changes in the cardiac energy metabolism that can lead to a loss of metabolic flexibility and to unfavorable clinical outcomes. We conducted an association analysis of 31 ASCVD phenotypes and 97 whole blood amino acids, acylcarnitines and derived ratios in the LIFE-Adult (n = 9646) and LIFE-Heart (n = 5860) studies, respectively. In addition to hundreds of significant associations, a total of 62 associations of six phenotypes were found in both studies. Positive associations of various amino acids and a range of acylcarnitines with decreasing cardiovascular health indicate disruptions in mitochondrial, as well as peroxisomal fatty acid oxidation. We complemented our metabolite association analyses with whole blood and peripheral blood mononuclear cell (PBMC) gene-expression analyses of fatty acid oxidation and ketone-body metabolism related genes. This revealed several differential expressions for the heart failure biomarker N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in peripheral blood mononuclear cell (PBMC) gene expression. Finally, we constructed and compared three prediction models of significant stenosis in the LIFE-Heart study using (1) traditional risk factors only, (2) the metabolite panel only and (3) a combined model. Area under the receiver operating characteristic curve (AUC) comparison of these three models shows an improved prediction accuracy for the combined metabolite and classical risk factor model (AUC = 0.78, 95%-CI: 0.76–0.80). In conclusion, we improved our understanding of metabolic implications of ASCVD phenotypes by observing associations with metabolite concentrations and gene expression of the mitochondrial and peroxisomal fatty acid oxidation. Additionally, we demonstrated the predictive potential of the metabolite profile to improve classification of patients with significant stenosis.
format Online
Article
Text
id pubmed-8949022
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89490222022-03-26 Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure Beuchel, Carl Dittrich, Julia Pott, Janne Henger, Sylvia Beutner, Frank Isermann, Berend Loeffler, Markus Thiery, Joachim Ceglarek, Uta Scholz, Markus Metabolites Article A variety of atherosclerosis and cardiovascular disease (ASCVD) phenotypes are tightly linked to changes in the cardiac energy metabolism that can lead to a loss of metabolic flexibility and to unfavorable clinical outcomes. We conducted an association analysis of 31 ASCVD phenotypes and 97 whole blood amino acids, acylcarnitines and derived ratios in the LIFE-Adult (n = 9646) and LIFE-Heart (n = 5860) studies, respectively. In addition to hundreds of significant associations, a total of 62 associations of six phenotypes were found in both studies. Positive associations of various amino acids and a range of acylcarnitines with decreasing cardiovascular health indicate disruptions in mitochondrial, as well as peroxisomal fatty acid oxidation. We complemented our metabolite association analyses with whole blood and peripheral blood mononuclear cell (PBMC) gene-expression analyses of fatty acid oxidation and ketone-body metabolism related genes. This revealed several differential expressions for the heart failure biomarker N-terminal prohormone of brain natriuretic peptide (NT-proBNP) in peripheral blood mononuclear cell (PBMC) gene expression. Finally, we constructed and compared three prediction models of significant stenosis in the LIFE-Heart study using (1) traditional risk factors only, (2) the metabolite panel only and (3) a combined model. Area under the receiver operating characteristic curve (AUC) comparison of these three models shows an improved prediction accuracy for the combined metabolite and classical risk factor model (AUC = 0.78, 95%-CI: 0.76–0.80). In conclusion, we improved our understanding of metabolic implications of ASCVD phenotypes by observing associations with metabolite concentrations and gene expression of the mitochondrial and peroxisomal fatty acid oxidation. Additionally, we demonstrated the predictive potential of the metabolite profile to improve classification of patients with significant stenosis. MDPI 2022-02-27 /pmc/articles/PMC8949022/ /pubmed/35323659 http://dx.doi.org/10.3390/metabo12030216 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Beuchel, Carl
Dittrich, Julia
Pott, Janne
Henger, Sylvia
Beutner, Frank
Isermann, Berend
Loeffler, Markus
Thiery, Joachim
Ceglarek, Uta
Scholz, Markus
Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title_full Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title_fullStr Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title_full_unstemmed Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title_short Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure
title_sort whole blood metabolite profiles reflect changes in energy metabolism in heart failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949022/
https://www.ncbi.nlm.nih.gov/pubmed/35323659
http://dx.doi.org/10.3390/metabo12030216
work_keys_str_mv AT beuchelcarl wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT dittrichjulia wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT pottjanne wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT hengersylvia wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT beutnerfrank wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT isermannberend wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT loefflermarkus wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT thieryjoachim wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT ceglarekuta wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure
AT scholzmarkus wholebloodmetaboliteprofilesreflectchangesinenergymetabolisminheartfailure